SpaceX Postpones Starship Launch Amid Anticipated RecordBreaking IPO New York Fed Study Rising Gas Prices Disproportionately Impact LowerIncome Households Geopolitical Risks Rise as Gaza Flotilla Activists Allege Mistreatment by Israeli Forces AI Adoption Shifts from Large Enterprises to Main Street Small Businesses Trump Indicates Iran Deal to Reopen Strait of Hormuz Largely Negotiated Traders Now See Next Fed Interest Rate Move as a Hike Following Inflation Surge GDYN Q1 2026 Earnings EPS Surprise Drives Positive Stock Momentum Regis Corporation RGS Q1 2026 Earnings Positive EPS of 060 Signals Operational Improvement HOFT Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Underlying Strength CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent ENVB Q4 2024 Earnings Deep EPS Miss Amid No Revenue Stock Rises 7 MeiraGTx Holdings plc MGTX Q1 2026 Earnings WiderthanExpected Loss Stings Investors Enphase Energy ENPH Holds Near Support as Solar Sector Faces Headwinds Rekor Systems REKR Faces Continued Pressure Near Key Support Level Origin Investment Corp I Warrant ORIQW Holds Steady at 016 Amid Tight Trading Range Kiora Pharmaceuticals KPRX Rallies 55 Key Levels to Watch After Recent Uptick LINKBANCORP LNKB Holds Steady as Stock Consolidates Between Support and Resistance Middle East Conflict and Rising Energy Costs Challenge Gulf Regions AI Data Center Ambitions Saratoga Investment Corp 600 Notes due 2027 SAT Q1 2026 Earnings Significant Miss as EPS Falls to 016 Next Technology Holding NXTT Surges 522 as Stock Tests Key Resistance at 148 GGAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Argentine Macro Environment JKHY Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Uncertainty CNH Q1 2026 Earnings EPS Surprises 754 Above Estimate Amid Challenging Environment PAVS Q2 2022 Earnings Massive EPS Miss Highlights Operational Challenges CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Logitech LOGI Q1 2026 Earnings EPS Beats Estimates Amidst Cautious Market Response Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development